Skip to content

Clinical trials

Completed Phase 3 Pancreatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Status: Completed Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20019
20022
20034
20044
20053
20065
20072
20083
20093
20102
20115
20123
20133
20145
20155
20163
20172
20184
20192
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center5
Cancer Advances Inc.3
AB Science2
Celgene2
Eastern Cooperative Oncology Group2
Eli Lilly and Company2
Federation Francophone de Cancerologie Digestive2
Fudan University2
Hoffmann-La Roche2
NCIC Clinical Trials Group2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms81
Neoplasms8
Stomach Neoplasms5
Bile Duct Neoplasms4
Carcinoma, Non-Small-Cell Lung4
Neoplasm Metastasis4
Adenocarcinoma3
Endocrine Gland Neoplasms3
Esophageal Neoplasms3
Pancreatic Diseases3

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.